Stock Price
1,513.00
Daily Change
11.35 0.76%
Monthly
10.62%
Yearly
26.96%
Q2 Forecast
1,478.96

Aurobindo Pharma reported INR82.63B in Debt for its fiscal quarter ending in March of 2025.





Debt Change Date
Cipla INR 4.38B 231.9M Mar/2025
Divis Laboratories Ltd INR 40M 40M Mar/2025
Dr.Reddys Laboratories INR 67.73B 9.19B Dec/2025
Hindustan Unilever INR 16.48B 30M Mar/2025
Sun Pharmaceuticals INR 23.62B 2.1B Mar/2025
UPL INR 250.99B 81.18B Mar/2025